IQVIA Financial Ratios
NYSE: IQVHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
IQVIA ratio analysis
IQVIA earned a net margin of 8.3% in FY 2025, down from 8.9% a year earlier. Gross margin was 33.3% compared with a median of 34.9% over the prior 9 years. Return on equity reached 20.9%, meaning IQVIA generated 0.21 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 2.42 versus 2.30 the year before, and the current ratio was 0.75. At the end of FY 2025, IQV traded at 28.7 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 17.1 to 161.8, with a median of 46.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
IQVIA financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 28.75 | 26.35 | 31.74 | 35.82 | 57.00 | 125.29 | 160.61 | 92.80 | 17.06 | 161.81 |
| Price / sales | 2.38 | 2.32 | 2.84 | 2.67 | 3.89 | 3.02 | 2.71 | 2.25 | 2.19 | 1.65 |
| Price / book | 5.96 | 5.90 | 6.96 | 6.67 | 8.94 | 5.71 | 5.01 | 3.49 | 2.67 | 1.31 |
| Gross margin | 33.3% | 34.9% | 35.0% | 34.9% | 33.5% | 34.0% | 34.2% | 35.2% | 52.5% | 53.0% |
| Operating margin | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 6.8% | 8.4% |
| Net margin | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.1% | 1.0% |
| Free cash flow margin | 12.6% | 13.7% | 10.0% | 11.0% | 16.6% | 11.8% | 7.5% | 7.6% | 6.2% | 10.1% |
| Return on equity (ROE) | 20.9% | 22.6% | 22.2% | 18.9% | 16.0% | 4.6% | 3.2% | 3.9% | 16.0% | 0.8% |
| Return on assets (ROA) | 4.5% | 5.1% | 5.1% | 4.3% | 3.9% | 1.1% | 0.8% | 1.1% | 5.6% | 0.3% |
| Debt / equity | 2.42 | 2.30 | 2.24 | 2.21 | 2.01 | 2.09 | 1.94 | 1.64 | 1.28 | 0.83 |
| Current ratio | 0.75 | 0.84 | 0.86 | 0.89 | 0.91 | 1.12 | 1.05 | 1.10 | 1.13 | 1.23 |
| Revenue growth | 5.9% | 2.8% | 4.0% | 3.9% | 22.1% | 2.4% | 6.5% | 6.9% | 41.6% | 19.9% |
| EPS growth | 4.7% | 2.7% | 27.4% | 15.6% | 246.2% | 49.0% | -22.6% | -78.4% | 1,121.3% | -84.7% |